Leon B. Lankford Jr.

Array ( [id] => 1277166 [patent_doc_number] => 06641526 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Development of normal offspring from oocytes injected with freeze-dried spermatozoa' [patent_app_type] => B1 [patent_app_number] => 09/177391 [patent_app_country] => US [patent_app_date] => 1998-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8851 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/641/06641526.pdf [firstpage_image] =>[orig_patent_app_number] => 09177391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1338952 [patent_doc_number] => 06593463 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems' [patent_app_type] => B1 [patent_app_number] => 09/175684 [patent_app_country] => US [patent_app_date] => 1998-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 5140 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593463.pdf [firstpage_image] =>[orig_patent_app_number] => 09175684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4343027 [patent_doc_number] => 06284539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Method for generating dopaminergic cells derived from neural precursors' [patent_app_type] => 1 [patent_app_number] => 9/169309 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14611 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284539.pdf [firstpage_image] =>[orig_patent_app_number] => 169309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436273 [patent_doc_number] => 06355859 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease' [patent_app_type] => B1 [patent_app_number] => 09/151592 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8287 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355859.pdf [firstpage_image] =>[orig_patent_app_number] => 09151592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4374537 [patent_doc_number] => 06288301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Treatment for juvenile diabetes' [patent_app_type] => 1 [patent_app_number] => 9/127028 [patent_app_country] => US [patent_app_date] => 1998-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 5783 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288301.pdf [firstpage_image] =>[orig_patent_app_number] => 127028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668647 [patent_doc_number] => 07094889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'AGE-1 polypeptides and related molecules and methods' [patent_app_type] => utility [patent_app_number] => 08/908453 [patent_app_country] => US [patent_app_date] => 1997-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13585 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094889.pdf [firstpage_image] =>[orig_patent_app_number] => 08908453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1500033 [patent_doc_number] => 06485964 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'TRANSGENIC MAMMALS LACKING EXPRESSION OF ERYTHROPOIETIN OR OF ERYTHROPOIETIN RECEPTOR, TRANSGENIC MAMMALS EXPRESSING CHIMERIC ERYTHROPOIETIN RECEPTORS, CONSTRUCTS FOR PRODUCING THE TRANSGENIC MAMMALS AND USES THEREFOR' [patent_app_type] => B1 [patent_app_number] => 08/839605 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12342 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/485/06485964.pdf [firstpage_image] =>[orig_patent_app_number] => 08839605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 515713 [patent_doc_number] => 07192933 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-20 [patent_title] => 'Use of a baculovirus to express an exogenous gene in a mammalian cell' [patent_app_type] => utility [patent_app_number] => 08/752032 [patent_app_country] => US [patent_app_date] => 1996-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5252 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/192/07192933.pdf [firstpage_image] =>[orig_patent_app_number] => 08752032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7639957 [patent_doc_number] => 06395959 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Nucleotide sequence encoding the enzyme I SceI and the use thereof' [patent_app_type] => B1 [patent_app_number] => 08/643732 [patent_app_country] => US [patent_app_date] => 1996-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 63 [patent_no_of_words] => 23516 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395959.pdf [firstpage_image] =>[orig_patent_app_number] => 08643732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1115869 [patent_doc_number] => 06800617 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-05 [patent_title] => 'Methods for restoring wild-type p53 gene function' [patent_app_type] => B1 [patent_app_number] => 08/035366 [patent_app_country] => US [patent_app_date] => 1993-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11839 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800617.pdf [firstpage_image] =>[orig_patent_app_number] => 08035366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4273237 [patent_doc_number] => 06307122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Infection of human neural xenografts' [patent_app_type] => 1 [patent_app_number] => 7/965901 [patent_app_country] => US [patent_app_date] => 1992-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6834 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/307/06307122.pdf [firstpage_image] =>[orig_patent_app_number] => 965901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1524585 [patent_doc_number] => 06353150 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Chimeric mammals with human hematopoietic cells' [patent_app_type] => B1 [patent_app_number] => 07/797493 [patent_app_country] => US [patent_app_date] => 1991-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6478 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/353/06353150.pdf [firstpage_image] =>[orig_patent_app_number] => 07797493 [rel_patent_id] =>[rel_patent_doc_number] =>)